Needle-free Injection System Market New Innovative Solutions to Boost Global Growth By 2026

Needle-free Injection System Market
Size, Trend, Outlook, Future Analysis
And Synthesis By 2026
Needle-free injection system is an innovative way to introduce medication into a patient’s body. Unlike
the conventional needle injection system, needle-free injection do not penetrate through the skin.
Needle-free injection system is steadily emerging as an efficient way to administer the medication with
better patient compliance. There are various advantages offered by needle-free injection system. This
system offers efficiency in administration of medication with better patient compliance especially for
children (vaccination), geriatric patients (palliative and other care), and patients with chronic diseases
such as diabetes, GI tract disease, and multiple sclerosis who need daily injection administration. Selfmedication becomes convenient with needle-free injection due to increased confidence amongst user for
self-medication and therefore it offers better treatment adherence and improved quality of life. Needlefree injection eliminates needle phobia, as medication is administered through system such as jet
injection system to the skin. Moreover, needle-free injection system allows drug delivery of even viscous
drug, which is difficult with conventional needle syringe system.
Ask For In-Depth Sample Copy @ https://www.coherentmarketinsights.com/insight/requestsample/1681
Market Dynamics
Needle-free injection system is continuously expanding its market footprint on account of
various factors. Increasing incidence of needle associated injuries and needle phobia amongst
children and adults is expected to drive growth of needle-free injection system market.
According to a study published in Behavioral Neurology, 2014, around 3-4 % of the world
population faces needle phobia. This impacts their hospital or clinic visits, as they avoid visiting
such facilities due to fear of exposure to needles. Needle phobia also impacts the vaccination
amongst children, as most of them perceives injecting vaccine as a painful procedure. According
to a study published in the Clinical Journal of Pain in 2015, there were 12 billion vaccination
every year worldwide, most of which required injecting drug with a needle syringe system.
Increasing demand for vaccines and other biologic products is another factor boosting growth of
the needle-free injection system market. According to the World Health Organization (WHO)
2018, globally around 86% of infants are vaccinated against 26 diseases, however, 19.5 million
children are unvaccinated leading to death of 2-3 million children every year. Chronic disease
such as diabetes often needs daily dose of insulin, which has to be administered through pain
needles. This may lead to lack of adherence to treatment due to lack of confidence to self-inject
insulin. Increasing research on biologics and biosimilar is another factor expected to fuel growth
of the market.
Report includes chapters which deeply display the following deliverable about industry :
• Needle-free Injection System Market Research Objective and Assumption
• Needle-free Injection System Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Needle-free Injection System Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Needle-free Injection System Market, By Regions
• Needle-free Injection System Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Needle-free Injection System Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Needle-free Injection System Market Manufacturing Cost Analysis including Key Raw Materials
and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Needle-free Injection System Market Forecast including Production, Consumption, Import and
Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Regional Insights
On the basis of geography, the global needle-free injection system market is segmented into North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is a dominant
region in the global needle-free injection system market. This is due to high prevalence of chronic
diseases such as diabetes and cancer. According to the American Cancer Society, 2018, cancer is the
second leading cause of death after cardio vascular disease in the U.S. Furthermore, around 1.7 million
new cancer cases were reported by 2017 in this region. Rising number of biologic drug approval in the
U.S. is another factor driving growth of needle-free injection system market. For instance, according to
the data published by the U.S. FDA (United States Food and Drug Administration) in the year 2017,
more than 20 biologic formulation received FDA approval. Asia Pacific is witnessing high growth in the
needle-free injection system market, as vaccine need is highest in this region. Moreover, this region has
high prevalence of lifestyle disease such as diabetes. According to the 2017 Diabetes Atlas report, there
were over 240 million diabetes patients in this region.
Competitive Landscape
Some of the key players operating in the market include Antares Pharma, Inc., Endo International plc,
Portal Instruments, Inc., Zogenix, PharmaJet, Bioject Medical Technologies Inc., Medical International
Technology, Inc., PenJet Corporation, INJEX Pharma AG, National Medical Products Inc., Valeritas, Inc.,
European Pharma Group, and Crossject SA.
Market Taxonomy
On the basis of Product Type: Prefilled, Fillable
On the basis of Delivery Site: Subcutaneous Injectors, Intramuscular Injectors, Intradermal Injectors
On the basis of Product Lifecycle: Disposable, Reusable
On the basis of Technology: Jet-based needle free injector, Spring-based needle free injector, Laserpowered needle free injector
On the basis of Application: Vaccine and other biologic product delivery, Insulin Delivery, Others
On the basis of End User: Hospitals & Clinics, Home based care
On the basis of Geography: North America, Latin America, Europe, Asia Pacific, Middle East, Africa
Browse Complete Report for More Information @
https://www.coherentmarketinsights.com/ongoing-insight/needle-free-injection-systemmarket-1681
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Increasing incidence of needle associated injuries and needle phobia amongst children and adults is expected to drive growth of the Market